40 Results

People

  1. Koehne
    Koehne
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Devlin
    Devlin
  5. Hassoun
    Hassoun
  6. Lendvai
    Lendvai
  7. Lesokhin
    Lesokhin
  8. Chung
    Chung
  9. Landgren
    Landgren
  10. Korde
    Korde

Groups

  1. Biostatistics Service (40)
  2. Center for Hematologic Malignancies (40)
  3. Department of Medicine (40)
  4. Epidemiology and Biostatistics (40)
  5. Hematologic Malignancies Research (40)
  6. Hematologic Malignancies, Division of (40)
  7. Bone Marrow Transplant (38)
  8. Survivorship Research (38)
  9. Myeloma (31)
  10. GSK Faculty (11)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Guenther Koehne"
  4. "Biostatistics Service"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (13)
Groups
  1. Biostatistics Service (40)
  2. Center for Hematologic Malignancies (40)
  3. Department of Medicine (40)
  4. Epidemiology and Biostatistics (40)
  5. Hematologic Malignancies Research (40)
  6. Hematologic Malignancies, Division of (40)

More Groups

People
  1. Guenther Koehne (40)
  2. Sergio Giralt (38)
  3. Heather Landau (32)
  4. Sean Devlin (31)
  5. Alexander Lesokhin (30)
  6. David Chung (30)

More People

Years
  1. 2020 (1)
  2. 2018 (2)
  3. 2017 (10)
  4. 2016 (5)
  5. 2015 (7)
  6. 2014 (2)

More Years

Publications
  1. Blood (14)
  2. Biology of Blood and Marrow Transplantation (13)
  3. Bone Marrow Transplantation (4)
  4. Leukemia and Lymphoma (4)
  5. Clinical Lymphoma, Myeloma and Leukemia (3)
  6. Haematologica (1)

More Publications

Publishers
  1. Elsevier Inc. (16)
  2. American Society of Hematology (14)
  3. Nature Publishing Group (5)
  4. Taylor & Francis Group (4)
  5. Ferrata Storti Foundation (1)

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
    Journal Article

    Lendvai, N.; Tsakos, I.; Devlin, S. M.; Schaffer, W. L.; Hassoun, H.; Lesokhin, A. M.; Landau, H.; Korde, N.; Mailankody, S.; Smith, E.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Journal Article

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Maloy, M.; Kenny, S.; Hassoun, H.; Korde, N. S.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Depth and timing of improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G. L.; Assal, A.; Hsu, M.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of re-immunization with inactivated vaccines in multiple myeloma patients on lenalidomide maintenance following autologous hematopoietic stem cell transplantation (auto HCT)
    Meeting Abstract

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Quantitative analysis of T1-weighted MRI images as a surrogate for fat content does not correlate with response or survival
    Meeting Abstract

    Amer, A.; Gunjan, S.; Benjamin, D.; Sean, D.; Molly, M.; Yousef, M.; David, C.; Guenther, K.; Nikoletta, L.; Heather, L.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Galinpepimut-S, a WT1-targeting immuno-oncology treatment, induces specific, robust and durable immune responses (IRs) in patients (Pts) with high-risk (HR) multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Korde, N.; Mailankody, S.; Heather, L.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Sarlis, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • WT1 heteroclitic epitope immunization following autologous stem cell transplantation in patients with high-risk multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Chung, D.; Landau, H.; Korde, N.; Mailankody, S.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Giralt, S.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G.; Assal, A.; Hsu, M.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save